LLY
Eli Lilly and Company
- Stock buybacks, 2025
- $4.1B
- YoY, 2025
- +64.3%
- 5-year CAGR
- +52.4%
- 10-year CAGR
- +18.5%
Stock buybacks
Stock buybacks by fiscal year
| Period | Buybacks | YoY |
|---|---|---|
| 2025 | $4.1B | +64.3% |
| 2024 | $2.5B | +233.3% |
| 2023 | $750M | −50.0% |
| 2022 | $1.5B | +20.0% |
| 2021 | $1.3B | +150.0% |
| 2020 | $500M | −88.6% |
| 2019 | $4.4B | +6.0% |
| 2018 | $4.2B | +1,284.5% |
| 2017 | $300M | −50.0% |
| 2016 | $600M | −19.9% |
| 2015 | $750M | −6.3% |
| 2014 | $800M | −52.9% |
| 2013 | $1.7B | +135.5% |
| 2012 | $721M | — |
| 2011 | $0 | — |
| 2010 | $0 | — |